The Correlations Of Activins And Follistatin With Viral Load, Liver Damage, Interleukin-6 And Tumour Necrosis Factor-α In Treatment Naive Patients With Chronic Hepatitis C Genotype 1 And 4: A Casecontrol Study | 19602
Journal of Clinical & Cellular Immunology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The correlations of activins and follistatin with viral load, liver damage, interleukin-6 and tumour necrosis factor-α in treatment naive patients with chronic hepatitis C genotype 1 and 4: A casecontrol study
3rd International Conference and Exhibition on Clinical & Cellular Immunology
Ahmed Mohammed Ashshi, Bassem Refaat, Adel Galal El-Shemi and Adnan AlZanbagi
Activins and follistatin are involved in the regulation of immune system and their importance in liver diseases
has recently emerged
To measure the effect(s) of chronic hepatitis C (CHC) genotype 1 and 4 on the serum concentrations of activin-A,
activin-B and follistatin, and to determine their correlations with viral load, liver damage, interleukin-6 (IL-6) and tumour
necrosis factor (TNF)-α.
Serum samples were collected from 20 male and 20 female treatment naive CHC genotype 1 and 4 Saudi patients
(10 males and 10 females for each genotype), to measure activin-A, activin-B and follistatin by ELISA and the results were
compared with 40 gender and age matched healthy participants. Additionally, the serum levels of the candidate proteins were
correlated with IL-6, TNF-α, viral load and AST platelet ratio index (APRI).
SerumIL-6, TNF-α,activin-A and activin-B were significantly increased, whereas serum follistatin was significantly
decreased, in both genders of CHC patients compared to control subjects.In both viral genotypes, activin-A was strongly and
positively correlated with the viral load, APRI, IL-6 and TNF-α, and negatively with albumin (P<0.01). Activin-B showed
similar correlations to activin-A but only in CHC genotype 1 patients and it was weaker than activin-A. No correlation was
detected for follistatin.
CHC genotype 1 and 4 significantly altered serum activinsand follistatin, and the dysregulation of activins/
follistatin axis could be associated with host immune response, viral replication and liver injury. More studies are required to
elucidate the role(s) and clinical value of activins and follistatin in CHC.
Ahmed Mohammed Ashshi has completed his PhD(1999) Doctor of Philosophy in Medical and Molecular Virology,Faculty of Medicine, University of Manchester,
United Kingdom(UK). AIBMS:(2001) Professional qualification in Medical Laboratory Sciences, Associate, Institute of Biomedical Sciences, United Kingdom (UK).
Dean, Faculty of Applied Medical Sciences, Umm Al Qura University, Makkah Asociate Professor of Medical and Molocular Virology, Faculty of Applied Medical
Sciences, Umm Al Qura University, Makkah, Kingdom of Saudi Arabia Chairman, Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm
Al Qura University, Makkah, Kingdom ofSaudi Arabia.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals